ZZPZH(SH:600436) Sou Hu Cai Jing·2025-07-07 15:35Core Viewpoint - Pianzaihuang has experienced a decline in stock price for eight consecutive trading days, with a cumulative drop of -2.33% [1] Company Overview - Zhangzhou Pianzaihuang Pharmaceutical Co., Ltd. is a time-honored Chinese enterprise primarily engaged in pharmaceutical manufacturing, established in 1956 and listed on the Shanghai Stock Exchange in 2003, with a current share capital of 603 million [1] Financial Performance - The financial report indicates that E Fund's E Fund CSI 300 Pharmaceutical ETF is among the top ten shareholders of Pianzaihuang, having reduced its holdings in the first quarter of this year [1] - Year-to-date return for Pianzaihuang is 1.83%, ranking 2076 out of 3422 in its category [2] Performance Metrics - Recent performance metrics show a weekly decline of -0.35%, a monthly decline of -1.71%, a quarterly increase of 6.69%, a six-month increase of 6.60%, and a year-to-date increase of 1.83% [2] - The average performance of similar funds shows a year-to-date return of 5.48% [2] Fund Management - The fund manager for E Fund CSI 300 Pharmaceutical ETF is Yu Haiyan, who has extensive experience in investment management and analysis [4][5]